Covidien endotracheal tube helps prevent pneumonia
This article was originally published in The Gray Sheet
Executive Summary
Covidien says its Mallinckrodt SealGuard Evac entdotracheal tube, launched Feb. 2 at the Society of Critical Care Medicine Congress in Nashville, is designed to reduce microaspiration of secretions into the lungs by 95% compared with products currently on the market with high-volume, low-pressure cuffs. The device also helps provide secretion drainage through an integrated suction lumen. Last fall, the company announced plans to target high-growth market segments in the respiratory care business, including devices to fight ventilator-associated pneumonia (1"The Gray Sheet" Sept. 15, 2008, p. 13). The product received 510(k) clearance on Oct. 2, 2008